| Identification | Back Directory | [Name]
[1,1'-Biphenyl]-3-carboxamide, 3'-[[3-(2-fluorophenyl)-5,6-dihydro-5-methylpyrrolo[3,4-c]pyrazol-2(4H)-yl]methyl]- | [CAS]
2374139-68-9 | [Synonyms]
P-CAB agent 1 [1,1'-Biphenyl]-3-carboxamide, 3'-[[3-(2-fluorophenyl)-5,6-dihydro-5-methylpyrrolo[3,4-c]pyrazol-2(4H)-yl]methyl]- | [Molecular Formula]
C26H23FN4O | [MOL File]
2374139-68-9.mol | [Molecular Weight]
426.49 |
| Hazard Information | Back Directory | [Uses]
P-CAB agent 1 (compound B19) is a highly potent potassium-competitive acid blocker agent with an IC50 value of 60.50 nM for H+/K+-ATPase. P-CAB agent 1 has acceptable oral absorption in rats. P-CAB agent 1 can be used for researching acid-related disorders (ARDs)[1]. | [in vivo]
P-CAB agent 1 has acceptable oral absorption in rats[1]. Pharmacokinetic Parameters of P-CAB agent 1 in female Sprague-Dawley rats[1].
| IV (2 mg/kg) | PO (8 mg/kg) | | AUC0-∞ (ug/L*hr) | 519.57 | 341.49 | | t1/2 (ng/mL) | 0.49 | 0.8 | | Cmax (ug/L) | 149.93 | 17 | | F (%) | | 16.43 |
| [References]
[1] Wang X, et al. Design, synthesis and biological evaluation of novel 5-methyl-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole derivatives as potent potassium-competitive acid blockers. Bioorg Med Chem. 2022 Jun 15;64:116765. DOI:10.1016/j.bmc.2022.116765 |
|
|